Who owns GILEAD SCIENCES, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of GILD from SEC Form 13F filings across 2,282 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 2,282 institutions disclosed 1.11B shares of GILEAD SCIENCES, INC. worth $140.50B — about 89.4% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
2,282
13F holders
$140.50B
value, 2026 filers
89.4%
of shares outstanding (1.11B sh)
192
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of GILD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 121.8M | $15.39B | 0.2% | 9.8% | +2.4% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 81.1M | $10.25B | 0.2% | 6.5% | +0.5% |
| 3 | FMR LLC | 66.9M | $8.45B | 0.4% | 5.4% | -7.0% |
| 4 | STATE STREET CORP | 61.2M | $7.73B | 0.2% | 4.9% | +2.3% |
| 5 | Capital World Investors | 41.0M | $5.18B | 0.6% | 3.3% | -0.7% |
| 6 | Invesco Ltd. | 39.8M | $5.03B | 0.4% | 3.2% | +156.5% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 35.3M | $4.46B | 0.2% | 2.8% | +0.5% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 30.1M | $3.80B | 0.2% | 2.4% | +1.1% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | 30.0M | $3.79B | 0.4% | 2.4% | +14.3% |
| 10 | MORGAN STANLEY | 24.0M | $3.03B | 0.2% | 1.9% | +3.0% |
| 11 | Dodge & Cox | 23.7M | $2.99B | 1.6% | 1.9% | -2.4% |
| 12 | NORGES BANKNEW | 22.0M | $2.78B | 0.3% | 1.8% | new |
| 13 | JPMORGAN CHASE & CO | 20.8M | $2.63B | 0.1% | 1.7% | -38.7% |
| 14 | Capital Research Global Investors | 19.4M | $2.45B | 0.3% | 1.6% | -28.5% |
| 15 | BANK OF AMERICA CORP /DE/ | 18.6M | $2.36B | 0.2% | 1.5% | -6.7% |
| 16 | Bank of New York Mellon Corp | 15.3M | $1.93B | 0.3% | 1.2% | +1.4% |
| 17 | NORTHERN TRUST CORP | 13.8M | $1.75B | 0.2% | 1.1% | +0.1% |
| 18 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 13.0M | $1.64B | 0.3% | 1% | -1.6% |
| 19 | WELLINGTON MANAGEMENT GROUP LLP | 12.7M | $1.60B | 0.3% | 1% | -6.2% |
| 20 | GOLDMAN SACHS GROUP INC | 10.8M | $1.36B | 0.1% | 0.9% | -2.6% |
| 21 | Legal & General Group Plc | 10.4M | $1.32B | 0.3% | 0.8% | -0.4% |
| 22 | Amundi | 9.8M | $1.23B | 0.3% | 0.8% | -7.3% |
| 23 | Nuveen, LLC | 8.3M | $1.05B | 0.3% | 0.7% | +6.4% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 8.2M | $1.03B | 0.1% | 0.7% | -0.3% |
| 25 | DIMENSIONAL FUND ADVISORS LP | 7.9M | $998.1M | 0.2% | 0.6% | +2.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.